DENTSPLY SIRONA Inc. $XRAY Shares Acquired by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 13.5% in the third quarter, Holdings Channel.com reports. The firm owned 1,800,822 shares of the medical instruments supplier’s stock after acquiring an additional 213,988 shares during the quarter. Commonwealth Equity Services LLC’s holdings in DENTSPLY SIRONA were worth $15,955,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in XRAY. Bfsg LLC lifted its stake in DENTSPLY SIRONA by 13.4% during the third quarter. Bfsg LLC now owns 22,230 shares of the medical instruments supplier’s stock worth $197,000 after purchasing an additional 2,620 shares in the last quarter. Chicago Partners Investment Group LLC raised its position in DENTSPLY SIRONA by 1,130.7% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 266,884 shares of the medical instruments supplier’s stock valued at $2,517,000 after purchasing an additional 245,199 shares during the last quarter. ARGA Investment Management LP acquired a new stake in DENTSPLY SIRONA during the 3rd quarter worth approximately $234,000. State of Wyoming increased its stake in DENTSPLY SIRONA by 54.5% in the 3rd quarter. State of Wyoming now owns 36,419 shares of the medical instruments supplier’s stock valued at $323,000 after buying an additional 12,842 shares during the period. Finally, Parcion Private Wealth LLC purchased a new position in DENTSPLY SIRONA during the third quarter worth about $139,000. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Piper Sandler lowered their price objective on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, October 9th. Barrington Research cut their target price on DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, October 26th. JPMorgan Chase & Co. reduced their price target on DENTSPLY SIRONA from $12.00 to $10.00 and set a “neutral” rating for the company in a report on Friday, November 6th. Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Friday, October 30th. Finally, Leerink Partners decreased their target price on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating on the stock in a research report on Wednesday, October 14th. Three research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $12.42.

DENTSPLY SIRONA Trading Up 1.7%

Shares of DENTSPLY SIRONA stock opened at $9.70 on Wednesday. The business’s fifty day moving average is $9.54 and its two-hundred day moving average is $11.25. The company has a quick ratio of 1.04, a current ratio of 1.63 and a debt-to-equity ratio of 1.47. DENTSPLY SIRONA Inc. has a fifty-two week low of $8.14 and a fifty-two week high of $14.76. The firm has a market cap of $1.92 billion, a PE ratio of 7.07, a P/E/G ratio of 1.36 and a beta of 0.87.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.02). DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The business had revenue of $836.00 million during the quarter, compared to analysts’ expectations of $861.68 million. During the same quarter last year, the firm earned $0.37 EPS. The firm’s quarterly revenue was down 7.5% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. Analysts anticipate that DENTSPLY SIRONA Inc. will post 1.24 earnings per share for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc. develops, manufactures and markets products and technologies for dental professionals. Its portfolio includes dental equipment and imaging systems, digital dentistry and CAD/CAM solutions, dental implants, endodontic and restorative products, and supplies used in preventive care. The company serves dental practices, laboratories and other customers around the world. Its products support a range of clinical activities, including diagnosis, treatment planning, restorative dentistry and oral hygiene.